日韩午夜精品视频,欧美私密网站,国产一区二区三区四区,国产主播一区二区三区四区

 

China not affected by Abbott's infant formula recall

0 CommentsPrint E-mail China Daily, September 23, 2010
Adjust font size:

A spokesman at Abbott Nutrition International said on Wednesday in Chicago that its voluntary recall of certain Similac brand powder infant formulas did not affect China market.

Steven B. Collens, director and head of public affairs at Abbott Nutrition International, told Xinhua in an exclusive telephone interview, "Consumers in China should be assured that no products distributed locally by Abbott Nutrition are affected by the recent proactive, voluntary recall of some Abbott Nutrition products in the United States, Puerto Rico, Guam and some countries in the Caribbean."

Collens further explained that Abbott initiated this recall due to a situation that was isolated to one production area in a single manufacturing facility in the United States. Abbott is recalling these products following an internal quality review.

The recall of these powder infant formulas includes: Certain Similac powder product lines offered in plastic containers and certain Similac powder product lines offered in sizes such as 8-ounce, 12.4-ounce and 12.9-ounce cans. No Abbott liquid infant formulas are impacted.

The company is implementing a plan to address this matter in the affected manufacturing facility, which is expected to be completed shortly. No other facilities or products are involved in this recall. Abbott has consulted with the US FDA regarding this recall.

Holger Liepmann, vice executive president of Abbott Nutrition, said "Abbott understands that parents expect to feed their children only the highest quality product. We are taking this action so that parents know that the infant formula products they provide unquestionably meet the highest quality standards for which they are known. We regret any inconvenience this situation poses to parents and consumers."

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

Print E-mail Bookmark and Share

Go to Forum >>0 Comments

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Racist, abusive and off-topic comments may be removed by the moderator.
Send your storiesGet more from China.org.cnMobileRSSNewsletter
主站蜘蛛池模板: 正安县| 双峰县| 额敏县| 炎陵县| 蓬安县| 长阳| 平邑县| 红河县| 舒兰市| 海宁市| 兴业县| 京山县| 永平县| 英超| 包头市| 广灵县| 新乡县| 大城县| 靖江市| 墨江| 岳阳县| 垦利县| 马关县| 嵊州市| 马尔康县| 独山县| 普宁市| 聂拉木县| 广州市| 呼图壁县| 湖口县| 沙洋县| 衡阳县| 哈密市| 吉木乃县| 突泉县| 临洮县| 堆龙德庆县| 凌海市| 深水埗区| 衡东县|